Gary highlights the troubling trend of regulatory capture, where large companies shape rules to their advantage, sidelining smaller competitors and public interest. He stresses the need for national and global AI agencies and expresses disappointment that the lessons from Covid-19 haven't led to a shift towards impactful AI development. While acknowledging some progress, he warns that without better AI systems capable of deep analysis, the potential for meaningful advancements in fields like healthcare remains unrealized.
